Search

Your search keyword '"Chung, Nellie Yuk-Fei"' showing total 32 results

Search Constraints

Start Over You searched for: Author "Chung, Nellie Yuk-Fei" Remove constraint Author: "Chung, Nellie Yuk-Fei"
32 results on '"Chung, Nellie Yuk-Fei"'

Search Results

1. The Molecular Landscape of Primary CNS Lymphomas (PCNSLs) in Children and Young Adults.

3. Clinical and mutational profiles of adult medulloblastoma groups

4. Pediatric low-grade gliomas can be molecularly stratified for risk

7. Molecular landscapes of longitudinalNF2/22q andnon‐ NF2/22q meningiomas show different life histories

9. Molecular landscapes of longitudinal NF2/22q and non‐NF2/22q meningiomas show different life histories.

10. Molecular landscape of IDH‐wild type, pTERT‐wild type adult glioblastomas

11. Combinations of Single-Gene Biomarkers Can Precisely Stratify 1,028 Adult Gliomas for Prognostication

13. PATH-23. GENOMIC LANDSCAPE OF IDH-MUTANT PRIMARY GLIOBLASTOMAS SHOWS DISTINCT CLINICAL AND MOLECULAR FEATURES AND THAT CDKN2A SHOULD BE SUPPLEMENTED WITH MGMTp AND G-CIMP FOR PRECISE PROGNOSTICATION

14. PATH-32. CLINICAL AND MUTATIONAL PROFILES OF ADULT MEDULLOBLASTOMA GROUPS

16. IDH mutant lower grade (WHO Grades II/III) astrocytomas can be stratified for risk by CDKN2A, CDK4 and PDGFRA copy number alterations

19. Low‐grade BRAF V600E mutant oligodendroglioma‐like tumors of children may show EGFR and MET amplification.

20. IDH mutant lower grade (WHO Grades II/III) astrocytomas can be stratified for risk by CDKN2A, CDK4 and PDGFRA copy number alterations.

22. Adult IDH wild-type lower-grade gliomas should be further stratified

23. Not all 1p/19q non-codeleted oligodendroglial tumors are astrocytic

24. MPTH-24COMBINATION GENETIC SIGNATURE STRATIFIES PROGNOSIS IN LOWER-GRADE GLIOMAS BUT IDH STATUS ALONE DOES NOT SUPERSEDE HISTOLOGIC GRADES

25. Pediatric low-grade gliomas can be molecularly stratified for risk.

26. Biomarker-based prognostic stratification of young adult glioblastoma

27. Combination genetic signature stratifies lower-grade gliomas better than histological grade

29. A study of tumor suppressor genes in multiple myeloma.

30. TERTpromoter mutations contribute to subset prognostication of lower-grade gliomas

31. The molecular history of IDH‐mutant astrocytomas without adjuvant treatment.

32. Biomarker-based prognostic stratification of young adult glioblastoma.

Catalog

Books, media, physical & digital resources